Gyeongsangbuk-do, South Korea

Moon Nyeo Park

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Moon Nyeo Park in Biocompatible Keratocyte Progenitor Cells

Introduction

Moon Nyeo Park is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of regenerative medicine, particularly in the differentiation of keratocyte progenitor cells. His innovative work aims to enhance treatment options for patients with corneal issues.

Latest Patents

Moon Nyeo Park holds a patent for a method that facilitates the differentiation into biocompatible keratocyte progenitor cells. This method involves providing human turbinate mesenchymal stem cells (hTMSCs) from a tissue source and culturing them in a keratocyte differentiation medium supplemented with keratocyte growth factor (KGF). This groundbreaking approach allows for the creation of a differentiable keratocyte precursor cell composition, which was previously unattainable in conventional methods. The injection of this keratocyte progenitor cell composition into patients can yield short-term treatment effects while maintaining corneal transparency.

Career Highlights

Moon Nyeo Park is affiliated with the Postech Academy-Industry Foundation, where he continues to advance his research and innovations. His work is pivotal in the field of cell differentiation and regenerative therapies.

Collaborations

He collaborates with esteemed colleagues, including Dong-Woo Cho and Sung Won Kim, to further enhance the impact of his research.

Conclusion

Moon Nyeo Park's contributions to the field of biocompatible keratocyte progenitor cells represent a significant advancement in regenerative medicine. His innovative methods hold promise for improving patient outcomes in corneal treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…